Company Overview of A2A Pharmaceuticals, Inc.
A2A Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel drugs for treating antibiotic-resistant bacterial infections, tuberculosis, and cancer. The company applies its therapeutic design methodology to inhibiting protein-protein interactions; and bioinformatics methodology to gram-negative bacterial species. It also offers consulting services. The company was founded in 2016 and is headquartered in New York, New York.
New York, NY
Founded in 2016
Key Executives for A2A Pharmaceuticals, Inc.
A2A Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact A2A Pharmaceuticals, Inc., please visit www.a2apharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.